Trial
NCT01240304
A Phase II Study to Assess the Efficacy and Safety of Preoperative Chemo With Radiation Therapy for Patients With Borderline Unresectable Adenocarcinoma of the Pancreas
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Arkansas
Collaborators
—
Condition
Pancreatic Cancer
Intervention
Gemcitabine
Why stopped
no subjects enrolled
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-12-10